Biotech IPO Master Is Still Setting Up New Biotechs And Hatching More Deals

January 13, 2017 | Vivek Ramaswamy blindsided the biotech industry with a record-setting IPO for the mystery biotech Axovant. The one-time hedge fund maestro turned drug entrepreneur has set up three more companies and taken one of them public at near supersonic speed, all while busily in-licensing drugs from a growing list of suppliers. ENDPOINTS NEWS